Vai al contenuto principale
Oggetto:
Oggetto:

Modulo Scienze Neuropsicomotorie X

Oggetto:

Neuro and Psychomotor Science Module X

Oggetto:

Anno accademico 2023/2024

Codice attività didattica
MED3025D
Docente
Francesca Rossi (Docente Titolare dell'insegnamento)
Corso di studio
[f070-c709] TERAPIA DELLA NEURO E PSICOMOTRICITÀ DELL'ETÀ EVOLUTIVA (ABILITANTE ALLA PROFESSIONE SANITARIA DI TERAPISTA DELLA NEURO E PSICOMOTRICITÀ DELL'ETÀ EVOLUTIVA)
Anno
2° anno
Periodo
Da definire
Tipologia
Caratterizzante
Crediti/Valenza
1
SSD attività didattica
MED/48 - scienze e tecniche riabilitative
Erogazione
Tradizionale
Lingua
Italiano
Frequenza
Obbligatoria
Tipologia esame
Quiz
Tipologia unità didattica
modulo
Insegnamento integrato
RIABILITAZIONE MALATTIE NEUROMUSCOLARI E CINESIOLOGIA SPECIALE (270/04) (MED3025)
Prerequisiti

Sviluppo neuropsicomotorio del bambino, fisiologia dell'apparato articolare e muscolare, fisiologia del sistema nervoso centrale e periferico.


Neuropsychomotor development during infancy, musculoskeletal physiology, CNS and PNS physiology.
Oggetto:

Sommario insegnamento

Oggetto:

Obiettivi formativi

Il corso si pone l'obiettivo di fornire le basi teoriche e pratiche della valutazione dei soggetti in età evolutiva affetti da varie malattie neuromuscolari, ed in diverse fasi della storia naturale della malattia.

The teaching aims to provide the theoretical and practice basis of assessment of subjects in developmental age affected by various neuromuscolar diseases, and in different stages of the natural hystory of the disease. 

 

Oggetto:

Risultati dell'apprendimento attesi

Ci aspetta che i partecipanti al corso acquisiscano le nozioni relative alla conoscenza degli strumenti di valutazione riabilitativa validati, standardizzati e maggiormente utilizzati in ambito internazionale, nei soggetti affetti da diverse malattie neuromuscolari.

It is expected that the course applicants acquire the notions related to the knowledge of validated, standardized and mainly used in an international context, in subjects affected by various neuromuscolar diseases, rehabilitative assessment tools. 

Oggetto:

Programma

1- Semeiotica Neuromuscolare: dall'osservazione alla lettura del segno.

2-  La valutazione riabilitativa nella malattie neuromuscolari: l'esame muscolare, l'esame articolare, le prove a tempo, le scale di valutazione funzionale.

3- La valutazione riabilitativa delle persone affette da:

- DMD nella varie fasi della malattia: le indicazioni delle Linee Guida internazionali, nazionali e della Consulta Ministeriale sulle malattie neuromuscolari del Ministero della Salute. La Scala di valutazione North Star Ambulatory Assessment, il Six Minute Walk Test, l'Hammersmith DMD, l'EK2, la scheda di valutazione Seating Clinic e la Scala PUL.

- SMA nelle diverse forme: le indicazioni delle Linee Guida internazionali e nazionali. La Scala di valutazione Chop Intend, l'Hammersmith Expanded ed il Revised Upper Limb Module.

Neuromuscular semeiotics: from observation to reading the sign.

2- Rehabilitation evaluation in neuromuscular diseases: muscle examination, joint examination, time tests, functional assessment scales.

3- Rehabilitation of persons with:

- DMD in the various stages of the disease: the guidelines of the international, national guidelines and the Ministerial Council on neuromuscular diseases of the Ministry of Health. The North Star Ambulatory Assessment Evaluation Scale, the Six Minute Walk Test, the Hammersmith DMD, the EK2, the seating Clinic Evaluation Board and the PUL Scale.

- SMA in the various forms: the indications of the international and national guidelines. The Chop intend Evaluation Scale, the Hammersmith expanded and the revised upper limb module. 

 

Oggetto:

Modalità di insegnamento

Lezioni frontali con impiego di slides e filmati. Esercitazioni pratiche e discussione in gruppo di casi clinici.

Frontal lectures using slides and movies. Practice exercise and group discussion about clinical cases.

Oggetto:

Modalità di verifica dell'apprendimento

Test scritto.

Written test.

Oggetto:

Attività di supporto


Nessuna


None

Testi consigliati e bibliografia

Oggetto:

 -          Ferrari A. (1998), "Malattie neuromuscolari appunti di clinica e riabilitazione". Ghedini Editore

-          Sussmann M. et al. (2002), "Duchenne Muscular Dystrophy". Journal of the AmericanAcademy of Orthopaedic Surgeons, 10(2): 138-151.

-          Bushby K. et al. (2018), "Diagnosis and management of Duchenne Muscular Dystrophy. Part 1:diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management." Lancet Neurol. 2018 Jan; 17: 251-267.

-  Bushby K. et al. (2018), "Diagnosis and management of Duchenne Muscular Dystrophy. Part 2: respipratory, cardiac, bone health, and ortopaedic management." Lancet Neurol. 2018 Jan; 17: 347-61.

- Bushby K. at al. (2018), "Diagnosis and mangement of Duchenne Muscular Dystrophy. Part 3: prymary care, emergency management, phycosocial care, and transition of care across the lifespan." Lancet Neurol. 2018 Jan; 17: 1-10.

-          SIMFER (2002), "Linee guida per la riabilitazione delle malattie neuromuscolari infantili di origine genetica".

-          Craig M. McDONALD et al. (2009), "The 6-minute walk test as a new outcome measure in Duchenne Muscular Dystrophy". Muscle and Nerve, April 2010: 500-510.

-          Mazzone E. et al. (2010), "North Star Ambulatory Assessment,  6-minute walk test and timed items in ambulant boys with Duchenne Muscular Dystrophy". Neuromuscular Disorders 20 (2010): 712-716.

- Mercuri et al. (2016), "Revised North Star Ambulatory Assessment with young boys with Duchenne Muscular Dystrophy." Plos One 5, 2016: 1-9.

-          Lammers et al. (2008), "The six minute walk test: normal values for children of 4-11 years of age". Arch. Dis. Child. 2008, 93: 464-468.

-          Mazzone et al. (2009), Reliability of the North Star Ambulatory Assessment in a mulcentric setting. Neuromuscular Disorders, 19 (2009): 458-461.

-          Consulta Ministeriale sulle malattie Neuromuscolari. D.M. 07/02/2009.

-          Caracciolo A. et al. (1996), "Seating clinic: linee guida per la valutazione della postura nella disabilità motorie". SIVA Edizioni.

-          Mercuri E. et al. (2012), "International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy. Rome, 15-16 February 2012". Neuromuscular Disorders 22 (2012): 1025-1028.

-          Mazzone E. et al. (2012), "A critical review of functional assessment tools for upper limbs in Duchenne Muscular Dystrophy", Developmental Medicine and Child Neurology 2012, 54: 879-885.

 -          Steffensen B. et al. (2001), "Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy". Physiotherapy Research International, 6(3): 119-134.

-         Mercuri et al. (2018), "Diagnosis and management of Spinal Muscular Atrophy. Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care." Neuromuscular disorders 28 (2018): 103-115.

- Mercuri et al. (2018), "Diagnosis and management of Spinal Muscular Atrophy. Part 2: pulmunary and acute care; medications, supplements and immunizations; other organ system and ethics." Neuromuscular Disorders 28 (2018): 197-207.

-          Dubowitz V. (2009), "Ramblings in the history of spinal muscular atrophy". Neuromuscular Disorders 19 (2009) 69-73.

-          Dubowitz V. (1995), "Chaos in the classification of SMA: a possible resolution". Neuromuscular Disorders Vol. 5 N°1, pp 3-5, 1995.

-          Glanzman A. M. (2010), "The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability". Neuromuscular Disorders 20 (2010) 155-161.

-          Main M. et al. (2003), "The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation". European Journal of Paediatric Neurology, 7: 155-159.

-          Mazzone E. et al. (2011), "Assessing upper limb function in nonambulant SMA patients: development of a new module". Neuromuscular Disorders 21 (2011) 406-412.

-          O'Hagen et al. (2007), "An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients". Neuromuscular disorders 17 (2007) 693-697.

 -          Ferrari A. (1998), "Malattie neuromuscolari appunti di clinica e riabilitazione". Ghedini Editore

-          Sussmann M. et al. (2002), "Duchenne Muscular Dystrophy". Journal of the AmericanAcademy of Orthopaedic Surgeons, 10(2): 138-151.

-          Bushby K. et al. (2018), "Diagnosis and management of Duchenne Muscular Dystrophy. Part 1:diagnosis, and neuromuscular, rehabilitation, endocrine, and gastrointestinal and nutritional management." Lancet Neurol. 2018 Jan; 17: 251-267.

-  Bushby K. et al. (2018), "Diagnosis and management of Duchenne Muscular Dystrophy. Part 2: respipratory, cardiac, bone health, and ortopaedic management." Lancet Neurol. 2018 Jan; 17: 347-61.

- Bushby K. at al. (2018), "Diagnosis and mangement of Duchenne Muscular Dystrophy. Part 3: prymary care, emergency management, phycosocial care, and transition of care across the lifespan." Lancet Neurol. 2018 Jan; 17: 1-10.

-          SIMFER (2002), "Linee guida per la riabilitazione delle malattie neuromuscolari infantili di origine genetica".

-          Craig M. McDONALD et al. (2009), "The 6-minute walk test as a new outcome measure in Duchenne Muscular Dystrophy". Muscle and Nerve, April 2010: 500-510.

-          Mazzone E. et al. (2010), "North Star Ambulatory Assessment,  6-minute walk test and timed items in ambulant boys with Duchenne Muscular Dystrophy". Neuromuscular Disorders 20 (2010): 712-716.

- Mercuri et al. (2016), "Revised North Star Ambulatory Assessment with young boys with Duchenne Muscular Dystrophy." Plos One 5, 2016: 1-9.

-          Lammers et al. (2008), "The six minute walk test: normal values for children of 4-11 years of age". Arch. Dis. Child. 2008, 93: 464-468.

-          Mazzone et al. (2009), Reliability of the North Star Ambulatory Assessment in a mulcentric setting. Neuromuscular Disorders, 19 (2009): 458-461.

-          Consulta Ministeriale sulle malattie Neuromuscolari. D.M. 07/02/2009.

-          Caracciolo A. et al. (1996), "Seating clinic: linee guida per la valutazione della postura nella disabilità motorie". SIVA Edizioni.

-          Mercuri E. et al. (2012), "International workshop on assessment of upper limb function in Duchenne Muscular Dystrophy. Rome, 15-16 February 2012". Neuromuscular Disorders 22 (2012): 1025-1028.

-          Mazzone E. et al. (2012), "A critical review of functional assessment tools for upper limbs in Duchenne Muscular Dystrophy", Developmental Medicine and Child Neurology 2012, 54: 879-885.

 -          Steffensen B. et al. (2001), "Validity of the EK scale: a functional assessment of non-ambulatory individuals with Duchenne muscular dystrophy or spinal muscular atrophy". Physiotherapy Research International, 6(3): 119-134.

-         Mercuri et al. (2018), "Diagnosis and management of Spinal Muscular Atrophy. Part 1: Recommendations for diagnosis, rehabilitation, orthopedic and nutritional care." Neuromuscular disorders 28 (2018): 103-115.

- Mercuri et al. (2018), "Diagnosis and management of Spinal Muscular Atrophy. Part 2: pulmunary and acute care; medications, supplements and immunizations; other organ system and ethics." Neuromuscular Disorders 28 (2018): 197-207.

-          Dubowitz V. (2009), "Ramblings in the history of spinal muscular atrophy". Neuromuscular Disorders 19 (2009) 69-73.

-          Dubowitz V. (1995), "Chaos in the classification of SMA: a possible resolution". Neuromuscular Disorders Vol. 5 N°1, pp 3-5, 1995.

-          Glanzman A. M. (2010), "The Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND): Test development and reliability". Neuromuscular Disorders 20 (2010) 155-161.

-          Main M. et al. (2003), "The Hammersmith functional motor scale for children with spinal muscular atrophy: a scale to test ability and monitor progress in children with limited ambulation". European Journal of Paediatric Neurology, 7: 155-159.

-          Mazzone E. et al. (2011), "Assessing upper limb function in nonambulant SMA patients: development of a new module". Neuromuscular Disorders 21 (2011) 406-412.

-          O'Hagen et al. (2007), "An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patients". Neuromuscular disorders 17 (2007) 693-697.



Registrazione
  • Chiusa
    Apertura registrazione
    01/03/2020 alle ore 00:00
    Chiusura registrazione
    31/12/2022 alle ore 23:55
    Oggetto:
    Ultimo aggiornamento: 31/08/2023 11:57
    Non cliccare qui!